Global Fund support for strengthening TB Control and PMDT

Global Fund support for strengthening TB Control and PMDT

Joint Partners Forum, Geneva 27-30 April, 2015

content

• TB Portfolio

• NFM: Achievements and challenges for TB and PMDT

1

2

Grant Portfolio 2002-2014

Global Fund reports, 2014

30.5

16.5

8.3

4.8

0.7 0.2 0.0

5.0

10.0

15.0

20.0

25.0

30.0

35.0

Total HIV/AIDS Malaria TB HSS Other

GF Signed Grants ($US Billion)

0 5,0002,500

Kilometers ´

Global Fund Financing

Tuberculosis Grants: Coverage by Country

US$ 4.8 billion (Signed Amount)

US$ 3.8 billion (Disbursed Amount)

- 109 country programs,

- 1 multicountry program. Source: Global Fund Grant Data

Source: Global TB reports, 2013

Global Fund Financing for TB

75%

25%

Global Fund

OtherInternationalfunders

Funding for TB – 2002-2014

5

Top 10 countries

India

China

Indonesia

Pakistan

Bangladesh

Philippines

Ethiopia

Nigeria

Myanmar

Russian Federation

AELAC - EECA 15%

AELAC - LAC 6%

AELAC - SEA 7%

AME-CA 3%

AME-MENA

6%

AME-SEA 4% AME-WA

3%

High Impact - Africa I

8%

High Impact - Africa II

9%

High Impact - Asia 39%

Trends in TB Disbursements 2002-2013

0

100,000,000

200,000,000

300,000,000

400,000,000

500,000,000

600,000,000

700,000,000

800,000,000

2002 2003 2004 2005 2006 2007 2008 2009 2010 2011 2012 2013

Disbursements

Agenda

• TB Portfolio

• NFM: Achievements and challenges for TB and PMDT

1

2

Disease Split - NFM

50%

32%

18%

HIV/AIDS Malaria TB

8

9

NFM Summary: TB Submissions to Date

10

May (W1) June (W2) August (W3) October (W4) January (W5) April (W6) July (W7) Sept (W8)

TB-HIV

• Haiti

TB

• Bangladesh

• Cambodia

• Philippines

• Zimbabwe

TB-HIV

• Thailand

• Ukraine

• Zambia

TB

• Afghanistan

• Armenia

• Bhutan

• Comoros

• Multicountry

Western

Pacific

• Moldova

• Pakistan

• Papua New

Guinea

TB-HIV

• Chad

• Congo (DR)

• India

• Nigeria

• Panama

• Rwanda

• Sudan

• Viet Nam

• Zambia

TB

• Bulgaria

• Korea (DPR)

• Fiji

• Lao (PDR)

• Pakistan

• Romania

• Sao Tome

and Principe

• Solomon

Islands

• South Sudan

• Sri Lanka

TB-HIV

• Burkina Faso

• Cameroon

• Ethiopia

• Ghana

• Haiti

• Mozambique

• Sudan

• Swaziland

• Tanzania

• Togo

• Uganda

• Zanzibar

TB

• Azerbaijan

• Fiji

• Gambia

• Tajikistan

• Uzbekistan

TB-HIV

• Belize

• Botswana

• Burundi

• Cape Verde

• Djibouti

• India

• Kenya

• Kyrgyzstan

• Malawi

• Panama

• Suriname

• Togo

• Zanzibar

Regional

• ESCA-HC

• IGAD

• PAS

• SARCM

TB

• Belarus

• Benin

• Côte d’Ivoire

• Dominican

Republic

• Egypt

• El Salvador

• Gabon

• Guatemala

• Guyana

• Kosovo

• Madagascar

• Mauritania

• Nicaragua

• Niger

• Palestine

• Paraguay

• Peru

• Senegal

• Timor-Leste

TB-HIV

• Albania

• Angola

• Cameroon

• Congo

• Indonesia

• Lesotho

• Mali

• Multicountry

Caribbean

TB

• Georgia

• Guinea-

Bissau

• Liberia

• Somalia

• Syrian Arab

Republic

• Turkmenistn

TB-HIV

• South Africa

TB

• Bolivia

• Eritrea (TBC)

• Guinea

• Honduras

• Mongolia

• Morocco

(TBC)

• Multicountry

Americas

(TBC)

• Nepal

• Yemen

TB-HIV

• Central

African

Republic

• Namibia

(TBC)

• Sierra Leone

1 7 16 19 18 26 7 12

*Iteration

US$523 million Incentive Funding Awarded in

Windows 1- 4

Incentive funding breakdown by disease

(US$ millions)

400

300

0

100

250

150

50

350

450

200

500

550

TB TB/HIV

US$ 61

HIV/AIDS

US$

230

TB/HIV

Total

US$26

523

(100%)

As of 20/12/ 2015

11

30% 25% of awarded

incentive funding

for TB

Requested Funding by Module - TB Grants In selected 7 Board approved countries totaling US$285 million

12

TB Care and Prevention

26%

MDR-TB 18%

PSM 8%

HIS/M&E 6%

Health Community Workforce

6%

TB-HIV 5%

Program Management

23%

CSS 4%

Service Delivery

2%

Removing Legal Barriers

to Access 1%

Other 1%

50 concept notes reviewed

• 39 (78%) recommended for

grant-making

• 11 (22%) recommended for

iteration with TRP

This is a consistent percentage of

iterations requested as in third

window

6 concept notes discussed in fourth

window from past windows

• 1 from first window

• 2 from second window

• 3 from third window

All iterations moved to grant-making

From past windows Window 4

• Continued positive examples of rapid iteration with 100% success rate

• Large number of concept notes were strategically focused and evidence based

• Higher percentage of concept notes have clarifications to be cleared by the TRP

13

Summary of window 4 review outcomes

Lessons from review of Concept Notes

• Prioritization of interventions • NSP and Concept Note

• Basic services and scale-up

• Case detection for drug sensitive and MDR-TB scale-up • Challenge in setting targets

• Flattening/decreasing trend

• MDR-TB

• Estimates and prevalence survey results

• Laboratory services linking new diagnostics and lab plans

• Limited linkages and integration with other health programs • Integrated approach to MDR-TB care

• Balance diagnosis and treatment capacity

• Model of care

• Quality of treatment

• Joint TB and HIV programming

14

Framework for joint programming and joint concept note

HIV-specific TB-Specific Collaborative

TB/HIV activities

16

Months from submission to communication of results

17

Overall experience in applying

for funding from the Global

Fund

(N=191)

20%

61%

16%

3%

Very poor Poor Good Very Good

41%

29%31%

44%

50%47%

4%9%11%

4%5%5%8%6%6%

The Global Fund’s

increased focus on

inclusiveness

encouraged better

engagement with key

stakeholders (N=176)

The program split

discussion in

countries led to

better allocation

of resources

(N=117)

Was the application

process better than

the rounds-

based (N=188)

Evolve the funding model 77% of participants found new funding model an improvement

Timeline for strategy development 2017-2021

2014 2015 2016

9 10 11 12 1 2 3 4 5 6 7 8 9 10 11 12 1 2 3 4 5 6 7

Board

approval of

GF Strategy

Board approval

of goals and

strategic objectives

Analytical work

Consultations

Replenishment

preparatory meeting

(tbc)

Oct 2014

SIIC

1st SIIC

2015

3rd SIIC

2015

1st SIIC

2016

2nd SIIC

2015

2nd SIIC

2016

5th

Replenishment

(tbc)

18

Thanks

19